VBIV - VBI Vaccines GAAP EPS of -$0.10 misses by $0.02 revenue of $0.32M misses by $0.97M
- VBI Vaccines press release ( NASDAQ: VBIV ): Q3 GAAP EPS of -$0.10 misses by $0.02 .
- Revenue of $0.32M (+190.9% Y/Y) misses by $0.97M .
- VBI ended the third quarter of 2022 with $83.6 million in cash compared with $121.7 million in cash as of December 31, 2021.
- Shares -2.21% PM.
For further details see:
VBI Vaccines GAAP EPS of -$0.10 misses by $0.02, revenue of $0.32M misses by $0.97M